KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Inventory (2016 - 2026)

Merck has reported Inventory over the past 18 years, most recently at $6.5 billion for Q1 2026.

  • Quarterly Inventory rose 4.57% to $6.5 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.5 billion through Mar 2026, up 4.57% year-over-year, with the annual reading at $6.7 billion for FY2025, 8.99% up from the prior year.
  • Inventory was $6.5 billion for Q1 2026 at Merck, down from $6.7 billion in the prior quarter.
  • Over five years, Inventory peaked at $6.7 billion in Q4 2025 and troughed at $5.5 billion in Q2 2022.
  • The 5-year median for Inventory is $6.2 billion (2025), against an average of $6.2 billion.
  • Year-over-year, Inventory fell 9.81% in 2022 and then grew 11.04% in 2024.
  • A 5-year view of Inventory shows it stood at $5.9 billion in 2022, then increased by 7.56% to $6.4 billion in 2023, then fell by 3.92% to $6.1 billion in 2024, then grew by 8.99% to $6.7 billion in 2025, then decreased by 2.69% to $6.5 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Inventory are $6.5 billion (Q1 2026), $6.7 billion (Q4 2025), and $6.4 billion (Q3 2025).